Kurth K H, Debruyne F M, Hall R R, Denis L, Verbaes A, Bollack C, de Voogt H J, de Pauw M, Silvester R
Department of Urology, Rotterdam, The Netherlands.
Eur Urol. 1987;13(4):251-5. doi: 10.1159/000472789.
In a phase-II study of the EORTC GU Group 34 patients with metastatic renal cell carcinoma were treated by angioinfarction and delayed nephrectomy. The mortality of the procedure was 5.8%. One patient had a complete remission. 80% of the patients showed progression within 6 months after nephrectomy. The median survival of the patients was 25 weeks, 65% of the patients died within 1 year after nephrectomy.